UPDATE 2-US FDA extends review of Pfizer's experimental skin disease drug

Retrieved on: 2021-04-07 11:21:49

Tags for this article:

Click the tags to see associated articles and topics

UPDATE 2-US FDA extends review of Pfizer's experimental skin disease drug. View article details on hiswai:

Excerpt

Pfizer's abrocitinib was studied in adults and adolescents with moderate-to-severe atopic dermatitis, more commonly known has eczema, a chronic ...

Article found on: finance.yahoo.com